Genetic engineering of macrophages to acquire Phd2 +/- phenotype from induced plur...
| Grant number: | 18/06635-1 |
| Support type: | Regular Research Grants |
| Duration: | September 01, 2018 - November 30, 2020 |
| Field of knowledge: | Biological Sciences - Genetics - Human and Medical Genetics |
| Cooperation agreement: | University of Victoria |
| Mobility Program: | SPRINT - Projetos de pesquisa - Mobilidade |
| Principal Investigator: | Sang Won Han |
| Grantee: | Sang Won Han |
| Principal investigator abroad: | Stephanie Willerth |
| Institution abroad: | University of Victoria (UVic), Canada |
| Home Institution: | Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil |
| Associated research grant: | 15/20206-8 - Modulation of monocytes, macrophages and pericytes by the colony stimulating factor genes to treat murine limb ischemia, AP.TEM |
Abstract
The main objective of the current thematic project of FAPESP is to study the relationship between the colony- stimulating factors (CSFs) and the type of monocytes/macrophages recruited under normoxia and hypoxia, and to elaborate procedures of gene and cell therapy of ischemic diseases by recruiting more proresolutive macrophages or by implanting proresolutive macrophages genetically engineered from iPSC in the ischemic muscles. In general, these cells or vectors are injected directly into the skeletal muscle for therapy; however, the transfer rate of these cells and vectors is low because of leakage and loss of biological activity due to the high initial local concentration. In addition, the leakage of vectors and cells can also contaminate other tissues, which is a very worrying biosafety issue.Our proposal is to develop biomaterial-based vector and cell delivery systems consisting of hydrogels and biocompatible microspheres, such as fibrin or poly (µ-caprolactone). This collaborative project was elaborated based on the long experience of Dr. Willerth's group in the synthesis of biomaterials and the study of their interaction with proteins and cells, and many years of experience of gene therapy for ischemic diseases by Dr. Han's group. During the exchange missions, visits to research laboratories in cognate areas and a short course on biomaterials are scheduled. (AU)